Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Calumet Specialty Products
CLMT
$3.51B
| $1.03M | ﹤0.01% |
123,811
+14,293
| +13% | +$89K |
|
|
PX
2927
PUT
DELISTED
Praxair Inc
PX
| $1.03M | ﹤0.01% |
7,400
-26,500
| -78% | -$3.53M |
|
|
EXPR
2928
DELISTED
Express, Inc.
EXPR
| $1.03M | ﹤0.01% |
7,638
+1,239
| +19% | +$156K |
|
|
MIC
2929
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $1.03M | ﹤0.01% |
14,300
+11,800
| +472% | +$880K |
|
|
RMP
2930
DELISTED
Rice Midstream Partners LP
RMP
| $1.03M | ﹤0.01% |
49,247
+11,701
| +31% | +$240K |
|
|
LOGM
2931
DELISTED
LogMein, Inc.
LOGM
| $1.03M | ﹤0.01% |
9,363
-60,058
| -87% | -$6.73M |
|
2932
Medpace
MEDP
$16.4B
| $1.03M | ﹤0.01% |
32,268
-2,937
| -8% | -$89.7K |
|
2933
PUT
Textron
TXT
$15.2B
| $1.03M | ﹤0.01% |
19,100
-1,600
| -8% | -$79.5K |
|
2934
Crocs
CROX
$6.58B
| $1.03M | ﹤0.01% |
105,900
+70,625
| +200% | +$604K |
|
2935
Steris
STE
$22.7B
| $1.03M | ﹤0.01% |
11,642
+11,133
| +2,187% | +$944K |
|
|
TSE
2936
DELISTED
Trinseo
TSE
| $1.03M | ﹤0.01% |
15,318
-1,187
| -7% | -$79K |
|
2937
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$462M
| $1.03M | ﹤0.01% |
1,146
+1,086
| +1,810% | +$1.02M |
|
|
DOOR
2938
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.03M | ﹤0.01% |
14,836
+10,780
| +266% | +$744K |
|
|
DATA
2939
PUT
DELISTED
Tableau Software, Inc.
DATA
| $1.03M | ﹤0.01% |
13,700
-18,600
| -58% | -$1.29M |
|
|
ESV
2940
CALL
DELISTED
Ensco Rowan plc
ESV
| $1.03M | ﹤0.01% |
42,975
+15,025
| +54% | +$300K |
|
2941
Monro
MNRO
$411M
| $1.02M | ﹤0.01% |
18,301
+4,692
| +34% | +$220K |
|
2942
PUT
Fluor
FLR
$7.04B
| $1.02M | ﹤0.01% |
24,300
-400
| -2% | -$16.6K |
|
|
ENBL
2943
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.02M | ﹤0.01% |
64,023
-129,082
| -67% | -$1.93M |
|
2944
iShares Russell 2000 Value ETF
IWN
$14.6B
| $1.02M | ﹤0.01% |
8,233
+8,105
| +6,332% | +$955K |
|
|
ITCI
2945
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.02M | ﹤0.01% |
64,598
-77,839
| -55% | -$1.14M |
|
|
MDCO
2946
DELISTED
Medicines Co
MDCO
| $1.02M | ﹤0.01% |
27,475
+8,090
| +42% | +$298K |
|
|
GHL
2947
DELISTED
Greenhill & Co., Inc.
GHL
| $1.01M | ﹤0.01% |
61,118
+18,696
| +44% | +$316K |
|
2948
Element Solutions
ESI
$9.34B
| $1.01M | ﹤0.01% |
90,987
+20,121
| +28% | +$249K |
|
2949
Interparfums
IPAR
$3.95B
| $1.01M | ﹤0.01% |
24,563
-4,852
| -16% | -$187K |
|
2950
YPF
YPF
$19.1B
| $1.01M | ﹤0.01% |
45,393
-194,167
| -81% | -$4M |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.